← Leaderboards
Aaron Esser-Kahn
University Of Chicago
$13,698,058
Attributed
$13,698,058
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3M · FY2019–25$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,698,058 · 2
By mechanism
N01$13,698,058 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Chicago
Same institution · by research overlap
- Aubree L Gordon$35,956,094
- Sarah Cobey$9,898,587
- Jenna Guthmiller$1,932,976
- Chyung-Ru Wang$24,574,146
- Minglei Zhao$2,103,741
Others in their field
Other Emerging Leaders on “Adjuvant”
- Ted Ross · University Of Georgia$68,763,143
- Jay Evans · University Of Montana$43,101,450
- Valerie Fremont · Quality Biological, Inc.$19,261,930
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$10,000,000
- Garcia-Sastre Adolfo · Icahn School Of Medicine At Mount Sinai$8,560,974
- Lisa Morici · Tulane University Of Louisiana$8,296,098
Research focus
AdjuvantContractorAgonistVaccinesPathway InteractionsLibrariesInfluenza Virus VaccineCellsResponseImmuneT-LymphocyteInflammationVaccine EfficacyImmunogenicityPathogenPreventive VaccineAwardAnimal ModelHuman DiseaseFda ApprovedB-LymphocytesAntigensImmunologic MemoryAdaptive Immune System
Grant awards (9)
Discovery of Adjuvants that Direct T-cell Fates for Improved Safety and Efficacy in Vaccines Against Influenza and Tuberculosis$1,724,791
N01 · FY2025 · AI · contact PI
Discovery of Adjuvants that Direct T-cell Fates for Improved Safety and Efficacy in Vaccines Against Influenza and Tuberculosis$1,989,733
N01 · FY2024 · AI · contact PI
Discovery of adjuvants via novel modulation of innate immune pathways for vaccines against influenza$1,027,798
N01 · FY2024 · AI · contact PI
Discovery of adjuvants via novel modulation of innate immune pathways for vaccines against influenza$1,449,134
N01 · FY2023 · AI · contact PI
Discovery of adjuvants via novel modulation of innate immune pathways for vaccines against influenza$1,387,684
N01 · FY2022 · AI · contact PI
Discovery of adjuvants via novel modulation of innate immune pathways for vaccines against influenza$1,977,288
N01 · FY2021 · AI · contact PI
Discovery of adjuvants via novel modulation of innate immune pathways for vaccines against influenza$1,347,932
N01 · FY2020 · AI · contact PI
COVID Supplement$319,510
N01 · FY2020 · AI · contact PI
Discovery of adjuvants via novel modulation of innate immune pathways for vaccines against influenza$2,474,188
N01 · FY2019 · AI · contact PI